{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:08:17Z","timestamp":1787317697653,"version":"build-2736575974"},"reference-count":164,"publisher":"Oxford University Press (OUP)","issue":"Supplement_6","license":[{"start":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T00:00:00Z","timestamp":1697328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Flaviviruses are a genus within the Flaviviridae family of positive-strand RNA viruses and are transmitted principally through mosquito and tick vectors. These viruses are responsible for hundreds of millions of human infections worldwide per year that result in a range of illnesses from self-limiting febrile syndromes to severe neurotropic and viscerotropic diseases and, in some cases, death. A vaccine against the prototype flavivirus, yellow fever virus, has been deployed for 85 years and is highly effective. While vaccines against some medically important flaviviruses are available, others have proven challenging to develop. The emergence and spread of flaviviruses, including dengue virus and Zika virus, demonstrate their pandemic potential. This review highlights the gaps in knowledge that need to be addressed to allow for the rapid development of vaccines against emerging flaviviruses in the future.<\/jats:p>","DOI":"10.1093\/infdis\/jiad193","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T23:32:33Z","timestamp":1685575953000},"page":"S398-S413","source":"Crossref","is-referenced-by-count":17,"title":["A Prototype-Pathogen Approach for the Development of Flavivirus Countermeasures"],"prefix":"10.1093","volume":"228","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4148-1026","authenticated-orcid":false,"given":"Richard J","family":"Kuhn","sequence":"first","affiliation":[{"name":"Department of Biological Sciences, Purdue University , West Lafayette, Indiana , USA"},{"name":"Purdue Institute of Inflammation, Immunology, and Infectious Disease, Purdue University , West Lafayette, Indiana , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D T","family":"Barrett","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Texas Medical Branch , Galveston, Texas , USA"},{"name":"Sealy Institute for Vaccine Sciences, University of Texas Medical Branch , Galveston, Texas , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravinda M","family":"Desilva","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Harris","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Vaccinology, School of Public Health, University of California Berkeley , Berkeley, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura D","family":"Kramer","sequence":"additional","affiliation":[{"name":"School of Public Health, State University of New York at Albany , Albany, New York , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth R","family":"Montgomery","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale School of Medicine , New Haven, Connecticut , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore C","family":"Pierson","sequence":"additional","affiliation":[{"name":"Research Center, National Institute of Allergy and Infectious Diseases , National Institutes of Health, Bethesda, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sette","sequence":"additional","affiliation":[{"name":"Division of Vaccine Discovery, La Jolla Institute for Immunology , La Jolla, California , USA"},{"name":"Department of Medicine, University of California in San Diego , San Diego, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S","family":"Diamond","sequence":"additional","affiliation":[{"name":"Department of Medicine, Washington University School of Medicine , St Louis, Missouri , USA"},{"name":"Department of Molecular Microbiology and Pathology and Immunology, Washington University School of Medicine , St Louis, Missouri , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,10,18]]},"reference":[{"key":"2023101805453593200_jiad193-B1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1099\/vir.0.027490-0","article-title":"The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae","volume":"92","author":"Stapleton","year":"2011","journal-title":"J Gen Virol"},{"key":"2023101805453593200_jiad193-B2","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41564-020-0714-0","article-title":"The continued threat of emerging flaviviruses","volume":"5","author":"Pierson","year":"2020","journal-title":"Nat Microbiol"},{"key":"2023101805453593200_jiad193-B3","first-page":"325","article-title":"Zika virus and sexual transmission: a new route of transmission for mosquito-borne flaviviruses","volume":"90","author":"Hastings","year":"2017","journal-title":"Yale J Biol Med"},{"key":"2023101805453593200_jiad193-B4","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nrmicro.2016.125","article-title":"Zika virus\u2014reigniting the TORCH","volume":"14","author":"Coyne","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"2023101805453593200_jiad193-B5","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1080\/21505594.2021.1996059","article-title":"Pathogenesis and virulence of flavivirus infections","volume":"12","author":"van Leur","year":"2021","journal-title":"Virulence"},{"key":"2023101805453593200_jiad193-B6","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.jhep.2022.05.024","article-title":"Hepatopathology of flaviviruses","volume":"77","author":"Bailey","year":"2022","journal-title":"J Hepatol"},{"key":"2023101805453593200_jiad193-B7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/bs.aivir.2015.03.002","article-title":"The molecular biology of pestiviruses","volume":"93","author":"Tautz","year":"2015","journal-title":"Adv Virus Res"},{"key":"2023101805453593200_jiad193-B8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/bs.aivir.2017.07.003","article-title":"New leaves in the growing tree of pestiviruses","volume":"99","author":"Blome","year":"2017","journal-title":"Adv Virus Res"},{"key":"2023101805453593200_jiad193-B9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-3-7091-9300-6_5","article-title":"Serological and antigenical findings indicating pestivirus in man","volume":"7","author":"Giangaspero","year":"1993","journal-title":"Arch Virol Suppl"},{"key":"2023101805453593200_jiad193-B10","doi-asserted-by":"crossref","first-page":"17006","DOI":"10.1038\/nrdp.2017.6","article-title":"Hepatitis C virus infection","volume":"3","author":"Manns","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"2023101805453593200_jiad193-B11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.coviro.2019.02.008","article-title":"Taming a beast: lessons from the domestication of hepatitis C virus","volume":"35","author":"Luna","year":"2019","journal-title":"Curr Opin Virol"},{"key":"2023101805453593200_jiad193-B12","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00216-13","article-title":"Identification of rodent homologs of hepatitis C virus and pegiviruses","volume":"4","author":"Kapoor","year":"2013","journal-title":"mBio"},{"key":"2023101805453593200_jiad193-B13","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiac296","article-title":"Prototype pathogen approach for vaccine and monoclonal antibody development: a critical component of the NIAID plan for pandemic preparedness","volume":"227","author":"Cassetti","year":"2023","journal-title":"J Infect Dis"},{"key":"2023101805453593200_jiad193-B14","first-page":"281","volume-title":"Biotechnology: the renewable frontier","author":"Rice","year":"1986"},{"key":"2023101805453593200_jiad193-B15","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1128\/JVI.73.6.4611-4621.1999","article-title":"Genetic interaction of flavivirus nonstructural proteins NS1 and NS4A as a determinant of replicase function","volume":"73","author":"Lindenbach","year":"1999","journal-title":"J Virol"},{"key":"2023101805453593200_jiad193-B16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-virology-101416-041848","article-title":"The good, the bad, and the shocking: the multiple roles of dengue virus nonstructural protein 1 in protection and pathogenesis","volume":"5","author":"Glasner","year":"2018","journal-title":"Annu Rev Virol"},{"key":"2023101805453593200_jiad193-B17","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.celrep.2019.01.036","article-title":"Flavivirus NS1 triggers tissue-specific vascular endothelial dysfunction reflecting disease tropism","volume":"26","author":"Puerta-Guardo","year":"2019","journal-title":"Cell Rep"},{"key":"2023101805453593200_jiad193-B18","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1038\/s41467-020-19096-y","article-title":"Antibodies targeting epitopes on the cell-surface form of NS1 protect against Zika virus infection during pregnancy","volume":"11","author":"Wessel","year":"2020","journal-title":"Nat Commun"},{"key":"2023101805453593200_jiad193-B19","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02440-21","article-title":"Human monoclonal antibodies against NS1 protein protect against lethal West Nile virus infection","volume":"12","author":"Wessel","year":"2021","journal-title":"mBio"},{"key":"2023101805453593200_jiad193-B20","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1126\/science.abc0476","article-title":"Structural basis for antibody inhibition of flavivirus NS1-triggered endothelial dysfunction","volume":"371","author":"Biering","year":"2021","journal-title":"Science"},{"key":"2023101805453593200_jiad193-B21","article-title":"Antibody Fc characteristics and effector functions correlate with protection from symptomatic dengue virus type 3 infection","volume":"14","author":"Dias AG","year":"2022","journal-title":"Sci Transl Med"},{"key":"2023101805453593200_jiad193-B22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/bs.aivir.2020.08.003","article-title":"Structure-guided paradigm shifts in flavivirus assembly and maturation mechanisms","volume":"108","author":"Nicholls","year":"2020","journal-title":"Adv Virus Res"},{"key":"2023101805453593200_jiad193-B23","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1093\/emboj\/cdg270","article-title":"Structures of immature flavivirus particles","volume":"22","author":"Zhang","year":"2003","journal-title":"EMBO J"},{"key":"2023101805453593200_jiad193-B24","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1126\/science.1153264","article-title":"Structure of the immature dengue virus at low pH primes proteolytic maturation","volume":"319","author":"Yu","year":"2008","journal-title":"Science"},{"key":"2023101805453593200_jiad193-B25","doi-asserted-by":"crossref","first-page":"8475","DOI":"10.1128\/jvi.71.11.8475-8481.1997","article-title":"Proteolytic activation of tick-borne encephalitis virus by furin","volume":"71","author":"Stadler","year":"1997","journal-title":"J Virol"},{"key":"2023101805453593200_jiad193-B26","doi-asserted-by":"crossref","first-page":"8353","DOI":"10.1128\/JVI.00696-10","article-title":"Influence of pr-M cleavage on the heterogeneity of extracellular dengue virus particles","volume":"84","author":"Junjhon","year":"2010","journal-title":"J Virol"},{"key":"2023101805453593200_jiad193-B27","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of dengue virus: implications for flavivirus organization, maturation, and fusion","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"key":"2023101805453593200_jiad193-B28","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/375291a0","article-title":"The envelope glycoprotein from tick-borne encephalitis virus at 2 \u00c5 resolution","volume":"375","author":"Rey","year":"1995","journal-title":"Nature"},{"key":"2023101805453593200_jiad193-B29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.virol.2017.12.032","article-title":"The Zika virus envelope protein glycan loop regulates virion antigenicity","volume":"515","author":"Goo","year":"2018","journal-title":"Virology"},{"key":"2023101805453593200_jiad193-B30","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S1097-2765(01)00206-4","article-title":"Molecular organization of a recombinant subviral particle from tick-borne encephalitis virus","volume":"7","author":"Ferlenghi","year":"2001","journal-title":"Mol Cell"},{"key":"2023101805453593200_jiad193-B31","doi-asserted-by":"crossref","first-page":"11357","DOI":"10.1128\/JVI.77.21.11357-11366.2003","article-title":"Two distinct size classes of immature and mature subviral particles from tick-borne encephalitis virus","volume":"77","author":"Allison","year":"2003","journal-title":"J Virol"},{"key":"2023101805453593200_jiad193-B32","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.38970","article-title":"Epitope resurfacing on dengue virus-like particle vaccine preparation to induce broad neutralizing antibody","volume":"7","author":"Shen","year":"2018","journal-title":"Elife"},{"key":"2023101805453593200_jiad193-B33","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1073\/pnas.1304300110","article-title":"Dengue structure differs at the temperatures of its human and mosquito hosts","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023101805453593200_jiad193-B34","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1038\/s41467-020-16925-y","article-title":"High flavivirus structural plasticity demonstrated by a non-spherical morphological variant","volume":"11","author":"Morrone","year":"2020","journal-title":"Nat Commun"},{"key":"2023101805453593200_jiad193-B35","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.virol.2015.03.025","article-title":"Shake, rattle, and roll: impact of the dynamics of flavivirus particles on their interactions with the host","volume":"479\u2013480","author":"Kuhn","year":"2015","journal-title":"Virology"},{"key":"2023101805453593200_jiad193-B36","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202050069","article-title":"Extensive flavivirus E trimer breathing accompanies stem zippering of the post-fusion hairpin","volume":"21","author":"Medits","year":"2020","journal-title":"EMBO Rep"},{"key":"2023101805453593200_jiad193-B37","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01559-15","article-title":"Genotypic differences in dengue virus neutralization are explained by a single amino acid mutation that modulates virus breathing","volume":"6","author":"Dowd","year":"2015","journal-title":"mBio"},{"key":"2023101805453593200_jiad193-B38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002111","article-title":"A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus","volume":"7","author":"Dowd","year":"2011","journal-title":"PLoS Pathog"},{"key":"2023101805453593200_jiad193-B39","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00956-21","article-title":"Dengue virus serotype 1 conformational dynamics confers virus strain-dependent patterns of neutralization by polyclonal Sera","volume":"95","author":"VanBlargan","year":"2021","journal-title":"J Virol"},{"key":"2023101805453593200_jiad193-B40","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.3389\/fimmu.2018.02180","article-title":"Flavivirus receptors: diversity, identity, and cell entry","volume":"9","author":"Laureti","year":"2018","journal-title":"Front Immunol"},{"key":"2023101805453593200_jiad193-B41","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.chom.2012.08.009","article-title":"The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry","volume":"12","author":"Meertens","year":"2012","journal-title":"Cell Host Microbe"},{"key":"2023101805453593200_jiad193-B42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002655","article-title":"CLEC5A regulates Japanese encephalitis virus-induced neuroinflammation and lethality","volume":"8","author":"Chen","year":"2012","journal-title":"PLoS Pathog"},{"key":"2023101805453593200_jiad193-B43","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.cell.2018.02.054","article-title":"Common features of enveloped viruses and implications for immunogen design for next-generation vaccines","volume":"172","author":"Rey","year":"2018","journal-title":"Cell"},{"key":"2023101805453593200_jiad193-B44","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.coviro.2017.06.009","article-title":"Flavivirus structural heterogeneity: implications for cell entry","volume":"24","author":"Rey","year":"2017","journal-title":"Curr Opin Virol"},{"key":"2023101805453593200_jiad193-B45","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s41590-018-0210-3","article-title":"The immune response against flaviviruses","volume":"19","author":"Slon Campos","year":"2018","journal-title":"Nat Immunol"},{"key":"2023101805453593200_jiad193-B46","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3390\/v11100970","article-title":"Evasion of innate and intrinsic antiviral pathways by the Zika virus","volume":"11","author":"Serman","year":"2019","journal-title":"Viruses"},{"key":"2023101805453593200_jiad193-B47","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.chom.2016.05.009","article-title":"Zika virus targets human STAT2 to inhibit type I interferon signaling","volume":"19","author":"Grant","year":"2016","journal-title":"Cell Host Microbe"},{"key":"2023101805453593200_jiad193-B48","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1126\/science.1185181","article-title":"Cross-reacting antibodies enhance dengue virus infection in humans","volume":"328","author":"Dejnirattisai","year":"2010","journal-title":"Science"},{"key":"2023101805453593200_jiad193-B49","doi-asserted-by":"crossref","first-page":"8482","DOI":"10.1128\/JVI.00660-09","article-title":"Impact of quaternary organization on the antigenic structure of the tick-borne encephalitis virus envelope glycoprotein E","volume":"83","author":"Kiermayr","year":"2009","journal-title":"J Virol"},{"key":"2023101805453593200_jiad193-B50","doi-asserted-by":"crossref","first-page":"6052","DOI":"10.1016\/j.cell.2021.11.010","article-title":"The epitope arrangement on flavivirus particles contributes to Mab C10's extraordinary neutralization breadth across Zika and dengue viruses","volume":"184","author":"Sharma","year":"2021","journal-title":"Cell"},{"key":"2023101805453593200_jiad193-B51","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature14130","article-title":"Recognition determinants of broadly neutralizing human antibodies against dengue viruses","volume":"520","author":"Rouvinski","year":"2015","journal-title":"Nature"},{"key":"2023101805453593200_jiad193-B52","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124588","article-title":"Human antibody response to Zika targets type-specific quaternary structure epitopes","volume-title":"JCI Insight","author":"Collins","year":"2019"},{"key":"2023101805453593200_jiad193-B53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003458","article-title":"Dissection of antibody specificities induced by yellow fever vaccination","volume":"9","author":"Vratskikh","year":"2013","journal-title":"PLoS Pathog"},{"key":"2023101805453593200_jiad193-B54","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1073\/pnas.1200566109","article-title":"Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions","volume":"109","author":"de Alwis","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023101805453593200_jiad193-B55","doi-asserted-by":"crossref","first-page":"9557","DOI":"10.1128\/JVI.00080-06","article-title":"Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites","volume":"80","author":"Stiasny","year":"2006","journal-title":"J Virol"},{"key":"2023101805453593200_jiad193-B56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000060","article-title":"Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization","volume":"4","author":"Nelson","year":"2008","journal-title":"PLoS Pathog"},{"key":"2023101805453593200_jiad193-B57","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1038\/emboj.2009.245","article-title":"Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody","volume":"28","author":"Cherrier","year":"2009","journal-title":"EMBO J"},{"key":"2023101805453593200_jiad193-B58","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.aaf8505","article-title":"Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection","volume":"353","author":"Stettler","year":"2016","journal-title":"Science"},{"key":"2023101805453593200_jiad193-B59","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1126\/science.abb9425","article-title":"A broadly protective antibody that targets the flavivirus NS1 protein","volume":"371","author":"Modhiran","year":"2021","journal-title":"Science"},{"key":"2023101805453593200_jiad193-B60","doi-asserted-by":"crossref","first-page":"14769","DOI":"10.1038\/s41598-017-15039-8","article-title":"A Zika vaccine targeting NS1 protein protects immunocompetent adult mice in a lethal challenge model","volume":"7","author":"Brault","year":"2017","journal-title":"Sci Rep"},{"key":"2023101805453593200_jiad193-B61","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aax2388","article-title":"NS1 DNA vaccination protects against Zika infection through T cell-mediated immunity in immunocompetent mice","volume":"5","author":"Grubor-Bauk","year":"2019","journal-title":"Sci Adv"},{"key":"2023101805453593200_jiad193-B62","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa3787","article-title":"Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination","volume":"7","author":"Beatty","year":"2015","journal-title":"Sci Transl Med"},{"key":"2023101805453593200_jiad193-B63","doi-asserted-by":"crossref","first-page":"8384","DOI":"10.1073\/pnas.1704984114","article-title":"Antibody-based assay discriminates Zika virus infection from other flaviviruses","volume":"114","author":"Balmaseda","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023101805453593200_jiad193-B64","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-1-0716-0581-3_10","article-title":"Zika virus peptide ELISA (ZIKV-NS2B-concat ELISA) for detection of IgG antibodies to Zika virus infection","volume":"2142","author":"Mishra","year":"2020","journal-title":"Methods Mol Biol"},{"key":"2023101805453593200_jiad193-B65","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1038\/s41467-019-09914-3","article-title":"Differential human antibody repertoires following Zika infection and the implications for serodiagnostics and disease outcome","volume":"10","author":"Ravichandran","year":"2019","journal-title":"Nat Commun"},{"key":"2023101805453593200_jiad193-B66","doi-asserted-by":"crossref","first-page":"206","DOI":"10.15252\/embr.201745302","article-title":"The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design","volume":"19","author":"Rey","year":"2018","journal-title":"EMBO Rep"},{"key":"2023101805453593200_jiad193-B67","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.chom.2007.09.015","article-title":"Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner","volume":"2","author":"Mehlhop","year":"2007","journal-title":"Cell Host Microbe"},{"key":"2023101805453593200_jiad193-B68","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/JVI.02155-10","article-title":"Human IgG subclasses: in vitro neutralization of and in vivo protection against West Nile virus","volume":"85","author":"Hofmeister","year":"2011","journal-title":"J Virol"},{"key":"2023101805453593200_jiad193-B69","first-page":"42","article-title":"Harmonization of Zika neutralization assays by using the WHO international standard for anti-Zika virus antibody","volume-title":"NPJ Vaccines","author":"Mattiuzzo","year":"2019"},{"key":"2023101805453593200_jiad193-B70","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"Suppl 2","key":"2023101805453593200_jiad193-B71","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0264-410X(00)00038-4","article-title":"Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines","volume":"18","author":"Markoff","year":"2000","journal-title":"Vaccine"},{"key":"2023101805453593200_jiad193-B72","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1016\/j.vaccine.2007.08.024","article-title":"Field effectiveness of vaccination against tick-borne encephalitis","volume":"25","author":"Heinz","year":"2007","journal-title":"Vaccine"},{"key":"2023101805453593200_jiad193-B73","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4269\/ajtmh.2005.72.189","article-title":"Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in Peru","volume":"72","author":"Belmusto-Worn","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"2023101805453593200_jiad193-B74","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw9066","article-title":"Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody quality","volume":"12","author":"Maciejewski","year":"2020","journal-title":"Sci Transl Med"},{"key":"2023101805453593200_jiad193-B75","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/e08f911a-15ec-46d0-bede-83fdf3af1801","article-title":"Therapeutic efficacy of antibodies lacking Fcgamma receptor binding against lethal dengue virus infection is due to neutralizing potency and blocking of enhancing antibodies [corrected]","volume":"9","author":"Williams","year":"2013","journal-title":"PLoS Pathog"},{"key":"2023101805453593200_jiad193-B76","doi-asserted-by":"crossref","first-page":"11567","DOI":"10.1128\/JVI.05859-11","article-title":"Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanisms","volume":"85","author":"Vogt","year":"2011","journal-title":"J Virol"},{"key":"2023101805453593200_jiad193-B77","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1038\/s41467-018-07008-0","article-title":"Human antibodies targeting Zika virus NS1 provide protection against disease in a mouse model","volume":"9","author":"Bailey","year":"2018","journal-title":"Nat Commun"},{"key":"2023101805453593200_jiad193-B78","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1126\/science.aai8128","article-title":"IgG antibodies to dengue enhanced for FcgammaRIIIA binding determine disease severity","volume":"355","author":"Wang","year":"2017","journal-title":"Science"},{"key":"2023101805453593200_jiad193-B79","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.chom.2007.03.002","article-title":"The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection","volume":"1","author":"Pierson","year":"2007","journal-title":"Cell Host Microbe"},{"key":"2023101805453593200_jiad193-B80","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1099\/0022-1317-65-8-1261","article-title":"Flavivirus infection enhancement in macrophages: radioactive and biological studies on the effect of antibody on viral fate","volume":"65","author":"Gollins","year":"1984","journal-title":"J Gen Virol"},{"key":"2023101805453593200_jiad193-B81","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/289189a0","article-title":"Monoclonal anti-Fc receptor IgG blocks antibody enhancement of viral replication in macrophages","volume":"289","author":"Peiris","year":"1981","journal-title":"Nature"},{"key":"2023101805453593200_jiad193-B82","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/s41590-018-0227-7","article-title":"Characterization of a potent and highly unusual minimally enhancing antibody directed against dengue virus","volume":"19","author":"Renner","year":"2018","journal-title":"Nat Immunol"},{"key":"2023101805453593200_jiad193-B83","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.4049\/jimmunol.176.5.2825","article-title":"The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection","volume":"176","author":"Huang","year":"2006","journal-title":"J Immunol"},{"key":"2023101805453593200_jiad193-B84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006643","article-title":"A novel mechanism of antibody-mediated enhancement of flavivirus infection","volume":"13","author":"Haslwanter","year":"2017","journal-title":"PLoS Pathog"},{"key":"2023101805453593200_jiad193-B85","doi-asserted-by":"crossref","first-page":"29201","DOI":"10.1038\/srep29201","article-title":"Antibody-dependent enhancement of dengue virus infection in primary human macrophages; balancing higher fusion against antiviral responses","volume":"6","author":"Flipse","year":"2016","journal-title":"Sci Rep"},{"key":"2023101805453593200_jiad193-B86","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1126\/science.abk0058","article-title":"Antigenic evolution of dengue viruses over 20 years","volume":"374","author":"Katzelnick","year":"2021","journal-title":"Science"},{"key":"2023101805453593200_jiad193-B87","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/s41591-021-01392-9","article-title":"Evaluation of the extended efficacy of the Dengvaxia vaccine against symptomatic and subclinical dengue infection","volume":"27","author":"Salje","year":"2021","journal-title":"Nat Med"},{"key":"2023101805453593200_jiad193-B88","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1126\/science.abb6143","article-title":"Zika virus infection enhances future risk of severe dengue disease","volume":"369","author":"Katzelnick","year":"2020","journal-title":"Science"},{"key":"2023101805453593200_jiad193-B89","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of dengue serostatus on dengue vaccine safety and efficacy","volume":"379","author":"Sridhar","year":"2018","journal-title":"N Engl J Med"},{"key":"2023101805453593200_jiad193-B90","doi-asserted-by":"crossref","DOI":"10.1172\/JCI147066","article-title":"Dengue vaccine breakthrough infections reveal properties of neutralizing antibodies linked to protection","volume":"131","author":"Henein","year":"2021","journal-title":"J Clin Invest"},{"key":"2023101805453593200_jiad193-B91","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev-immunol-042617-053142","article-title":"Immune response to dengue and Zika","volume":"36","author":"Ngono","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"2023101805453593200_jiad193-B92","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/s41590-019-0477-z","article-title":"A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection","volume":"20","author":"Slon-Campos","year":"2019","journal-title":"Nat Immunol"},{"key":"2023101805453593200_jiad193-B93","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.immunol.20.100201.131730","article-title":"Lymphocyte-mediated cytotoxicity","volume":"20","author":"Russell","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"2023101805453593200_jiad193-B94","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.1254536","article-title":"T cell memory. Resident memory CD8 T cells trigger protective innate and adaptive immune responses","volume":"346","author":"Schenkel","year":"2014","journal-title":"Science"},{"key":"2023101805453593200_jiad193-B95","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.4049\/jimmunol.0801974","article-title":"A protective role for dengue virus-specific CD8+ T cells","volume":"182","author":"Yauch","year":"2009","journal-title":"J Immunol"},{"key":"2023101805453593200_jiad193-B96","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.4049\/jimmunol.1001709","article-title":"CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination","volume":"185","author":"Yauch","year":"2010","journal-title":"J Immunol"},{"key":"2023101805453593200_jiad193-B97","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s41467-017-01669-z","article-title":"Dengue virus-reactive CD8+ T cells mediate cross-protection against subsequent Zika virus challenge","volume":"8","author":"Wen","year":"2017","journal-title":"Nat Commun"},{"key":"2023101805453593200_jiad193-B98","doi-asserted-by":"crossref","first-page":"17036","DOI":"10.1038\/nmicrobiol.2017.36","article-title":"Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8+ T cells","volume":"2","author":"Wen","year":"2017","journal-title":"Nat Microbiol"},{"key":"2023101805453593200_jiad193-B99","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1305227110","article-title":"Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells","volume":"110","author":"Weiskopf","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023101805453593200_jiad193-B100","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.3389\/fimmu.2019.02125","article-title":"Human T cell response to dengue virus infection","volume":"10","author":"Tian","year":"2019","journal-title":"Front Immunol"},{"key":"2023101805453593200_jiad193-B101","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1172\/JCI118964","article-title":"Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a","volume":"98","author":"Mathew","year":"1996","journal-title":"J Clin Invest"},{"key":"2023101805453593200_jiad193-B102","doi-asserted-by":"crossref","first-page":"13323","DOI":"10.1128\/JVI.77.24.13323-13334.2003","article-title":"CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis","volume":"77","author":"Wang","year":"2003","journal-title":"J Virol"},{"key":"2023101805453593200_jiad193-B103","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00132-21","article-title":"Pre-existing T cell memory against Zika virus","volume":"95","author":"Schouest","year":"2021","journal-title":"J Virol"},{"key":"2023101805453593200_jiad193-B104","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2149\/tmh.2011-S09","article-title":"T-cell responses to dengue virus in humans","volume":"39","author":"Kurane","year":"2011","journal-title":"Trop Med Health"},{"key":"2023101805453593200_jiad193-B105","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nm887","article-title":"Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever","volume":"9","author":"Mongkolsapaya","year":"2003","journal-title":"Nat Med"},{"key":"2023101805453593200_jiad193-B106","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1016\/j.celrep.2019.11.098","article-title":"Molecular signatures of dengue virus-specific IL-10\/IFN-gamma co-producing CD4 T cells and their association with dengue disease","volume":"29","author":"Tian","year":"2019","journal-title":"Cell Rep"},{"key":"2023101805453593200_jiad193-B107","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3390\/vaccines10040612","article-title":"Transcriptomics of acute DENV-specific CD8+ T cells does not support qualitative differences as drivers of disease severity","volume":"10","author":"Grifoni","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"2023101805453593200_jiad193-B108","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.immuni.2022.04.010","article-title":"Inducing broad-based immunity against viruses with pandemic potential","volume":"55","author":"Sette","year":"2022","journal-title":"Immunity"},{"key":"2023101805453593200_jiad193-B109","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-1-4939-3670-0_6","article-title":"Lessons from the murine models of West Nile virus infection","volume":"1435","author":"McGruder","year":"2016","journal-title":"Methods Mol Biol"},{"key":"2023101805453593200_jiad193-B110","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev-virology-092818-015732","article-title":"Using macaques to address critical questions in Zika virus research","volume":"6","author":"Dudley","year":"2019","journal-title":"Annu Rev Virol"},{"key":"2023101805453593200_jiad193-B111","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3390\/v10110598","article-title":"Animal models of Zika virus infection during pregnancy","volume":"10:","author":"Caine","year":"2018","journal-title":"Viruses"},{"key":"2023101805453593200_jiad193-B112","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.coviro.2020.09.001","article-title":"Dengue mouse models for evaluating pathogenesis and countermeasures","volume":"43","author":"Chen","year":"2020","journal-title":"Curr Opin Virol"},{"key":"2023101805453593200_jiad193-B113","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat6114","article-title":"Immune responses at the maternal-fetal interface","volume":"4","author":"Ander","year":"2019","journal-title":"Sci Immunol"},{"key":"2023101805453593200_jiad193-B114","doi-asserted-by":"crossref","first-page":"S897","DOI":"10.1093\/infdis\/jix511","article-title":"Neuroviruses emerging in the Americas. Neurological implications of Zika virus infection in adults","volume":"216","author":"Munoz","year":"2017","journal-title":"J Infect Dis"},{"key":"2023101805453593200_jiad193-B115","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.3389\/fimmu.2018.02634","article-title":"Microphysiologic human tissue constructs reproduce autologous age-specific BCG and HBV primary immunization in vitro","volume":"9","author":"Sanchez-Schmitz","year":"2018","journal-title":"Front Immunol"},{"key":"2023101805453593200_jiad193-B116","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3390\/pathogens11030294","article-title":"Peculiarities of Zika immunity and vaccine development: lessons from dengue and the contribution from controlled human infection model","volume":"11","author":"Santiago","year":"2022","journal-title":"Pathogens"},{"key":"2023101805453593200_jiad193-B117","doi-asserted-by":"crossref","first-page":"S971","DOI":"10.1093\/infdis\/jix491","article-title":"Zika vaccines: role for controlled human infection","volume":"216","author":"Durbin","year":"2017","journal-title":"J Infect Dis"},{"key":"2023101805453593200_jiad193-B118","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2021.2002083","article-title":"A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson","volume":"18","author":"Patel","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"2023101805453593200_jiad193-B119","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1056\/NEJMp2202669","article-title":"Delivering pandemic vaccines in 100 days\u2014what will it take?","volume":"387","author":"Saville","year":"2022","journal-title":"N Engl J Med"},{"key":"2023101805453593200_jiad193-B120","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02147-16","article-title":"Human CD4+ T cell responses to an attenuated tetravalent dengue vaccine parallel those induced by natural infection in magnitude, HLA restriction, and antigen specificity","volume":"91","author":"Angelo","year":"2017","journal-title":"J Virol"},{"key":"2023101805453593200_jiad193-B121","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3390\/v11090823","article-title":"Twenty years of progress toward West Nile virus vaccine development","volume":"11","author":"Kaiser","year":"2019","journal-title":"Viruses"},{"key":"2023101805453593200_jiad193-B122","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMc0808664","article-title":"Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis","volume":"360","author":"Kumar","year":"2009","journal-title":"N Engl J Med"},{"key":"2023101805453593200_jiad193-B123","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1016\/j.vaccine.2011.06.062","article-title":"Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(R)) induced neutralizing antibody titers","volume":"29","author":"Van Gessel","year":"2011","journal-title":"Vaccine"},{"key":"2023101805453593200_jiad193-B124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1009468","article-title":"Dynamics and turnover of memory CD8 T cell responses following yellow fever vaccination","volume":"17","author":"Zarnitsyna","year":"2021","journal-title":"PLoS Comput Biol"},{"key":"2023101805453593200_jiad193-B125","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ni.2789","article-title":"Molecular signatures of antibody responses derived from a systems biology study of five human vaccines","volume":"15","author":"Li","year":"2014","journal-title":"Nat Immunol"},{"key":"2023101805453593200_jiad193-B126","doi-asserted-by":"crossref","first-page":"7919","DOI":"10.4049\/jimmunol.0803903","article-title":"The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response","volume":"183","author":"Akondy","year":"2009","journal-title":"J Immunol"},{"key":"2023101805453593200_jiad193-B127","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1084\/jem.20082292","article-title":"Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses","volume":"205","author":"Gaucher","year":"2008","journal-title":"J Exp Med"},{"key":"2023101805453593200_jiad193-B128","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.coviro.2020.09.004","article-title":"Dengue vaccine development by the year 2020: challenges and prospects","volume":"43","author":"Wilder-Smith","year":"2020","journal-title":"Curr Opin Virol"},{"key":"2023101805453593200_jiad193-B129","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf1517","article-title":"The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model","volume":"8","author":"Kirkpatrick","year":"2016","journal-title":"Sci Transl Med"},{"key":"2023101805453593200_jiad193-B130","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S1473-3099(20)30085-2","article-title":"Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial","volume":"20","author":"Stephenson","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2023101805453593200_jiad193-B131","doi-asserted-by":"crossref","first-page":"16509","DOI":"10.1038\/s41598-018-34735-7","article-title":"Purified inactivated Zika vaccine candidates afford protection against lethal challenge in mice","volume":"8","author":"Baldwin","year":"2018","journal-title":"Sci Rep"},{"key":"2023101805453593200_jiad193-B132","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(17)33106-9","article-title":"Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials","volume":"391","author":"Modjarrad","year":"2018","journal-title":"Lancet"},{"key":"2023101805453593200_jiad193-B133","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41467-017-00737-8","article-title":"A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage","volume":"8","author":"Shan","year":"2017","journal-title":"Nat Commun"},{"key":"2023101805453593200_jiad193-B134","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nm.4322","article-title":"A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models","volume":"23","author":"Shan","year":"2017","journal-title":"Nat Med"},{"key":"2023101805453593200_jiad193-B135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005608","article-title":"Zika virus-like particle (VLP) based vaccine","volume":"11","author":"Boigard","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"2023101805453593200_jiad193-B136","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.3389\/fimmu.2018.02464","article-title":"A recombinant subunit based Zika virus vaccine is efficacious in non-human primates","volume":"9","author":"Medina","year":"2018","journal-title":"Front Immunol"},{"key":"2023101805453593200_jiad193-B137","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg4084","article-title":"Designed, highly expressing, thermostable dengue virus 2 envelope protein dimers elicit quaternary epitope antibodies","volume":"7","author":"Kudlacek","year":"2021","journal-title":"Sci Adv"},{"key":"2023101805453593200_jiad193-B138","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1038\/s41467-018-05276-4","article-title":"A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein","volume":"9","author":"Li","year":"2018","journal-title":"Nat Commun"},{"key":"2023101805453593200_jiad193-B139","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.aah6157","article-title":"Protective efficacy of multiple vaccine platforms against Zika virus challenge in Rhesus monkeys","volume":"353","author":"Abbink","year":"2016","journal-title":"Science"},{"key":"2023101805453593200_jiad193-B140","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41541-022-00464-2","article-title":"Measles-based Zika vaccine induces long-term immunity and requires NS1 antibodies to protect the female reproductive tract","volume":"7","author":"Kurup","year":"2022","journal-title":"NPJ Vaccines"},{"key":"2023101805453593200_jiad193-B141","doi-asserted-by":"crossref","first-page":"17385","DOI":"10.1038\/s41598-018-35724-6","article-title":"A vaccine based on a modified vaccinia virus Ankara vector expressing Zika virus structural proteins controls Zika virus replication in mice","volume":"8","author":"Perez","year":"2018","journal-title":"Sci Rep"},{"key":"2023101805453593200_jiad193-B142","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7326\/M20-5306","article-title":"A double-blind, randomized, placebo-controlled phase 1 study of Ad26.ZIKV.001, an Ad26-vectored anti-Zika virus vaccine","volume":"174","author":"Salisch","year":"2021","journal-title":"Ann Intern Med"},{"key":"2023101805453593200_jiad193-B143","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.06.040","article-title":"Vaccine mediated protection against Zika virus-induced congenital disease","volume":"170","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"2023101805453593200_jiad193-B144","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nature18952","article-title":"Vaccine protection against Zika virus from Brazil","volume":"536","author":"Larocca","year":"2016","journal-title":"Nature"},{"key":"2023101805453593200_jiad193-B145","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1126\/science.aai9137","article-title":"Rapid development of a DNA vaccine for Zika virus","volume":"354","author":"Dowd","year":"2016","journal-title":"Science"},{"key":"2023101805453593200_jiad193-B146","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba5068","article-title":"Development of a potent Zika virus vaccine using self-amplifying messenger RNA","volume":"6","author":"Luisi","year":"2020","journal-title":"Sci Adv"},{"key":"2023101805453593200_jiad193-B147","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature21428","article-title":"Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination","volume":"543","author":"Pardi","year":"2017","journal-title":"Nature"},{"key":"2023101805453593200_jiad193-B148","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","article-title":"Modified mRNA vaccines protect against Zika virus infection","volume":"168","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"2023101805453593200_jiad193-B149","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0140-6736(17)33105-7","article-title":"Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials","volume":"391","author":"Gaudinski","year":"2018","journal-title":"Lancet"},{"key":"2023101805453593200_jiad193-B150","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1056\/NEJMoa1708120","article-title":"Safety and immunogenicity of an anti-Zika virus DNA vaccine\u2014preliminary report","volume":"385","author":"Tebas","year":"2021","journal-title":"N Engl J Med"},{"key":"2023101805453593200_jiad193-B151","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41541-018-0072-6","article-title":"Incorporation of NS1 and prM\/M are important to confer effective protection of adenovirus-vectored Zika virus vaccine carrying E protein","volume":"3","author":"Liu","year":"2018","journal-title":"NPJ Vaccines"},{"key":"2023101805453593200_jiad193-B152","first-page":"22","article-title":"Flavivirus NS1 and its potential in vaccine development","volume":"9","author":"Carpio","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"2023101805453593200_jiad193-B153","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/s41590-021-00966-6","article-title":"Protective Zika vaccines engineered to eliminate enhancement of dengue infection via immunodominance switch","volume":"22","author":"Dai","year":"2021","journal-title":"Nat Immunol"},{"key":"2023101805453593200_jiad193-B154","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1743-422X-9-115","article-title":"Manipulation of immunodominant dengue virus E protein epitopes reduces potential antibody-dependent enhancement","volume":"9","author":"Hughes","year":"2012","journal-title":"Virol J"},{"key":"2023101805453593200_jiad193-B155","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102079","article-title":"A conserved set of mutations for stabilizing soluble envelope protein dimers from dengue and Zika viruses to advance the development of subunit vaccines","volume":"298","author":"Phan","year":"2022","journal-title":"J Biol Chem"},{"key":"2023101805453593200_jiad193-B156","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jcv.2018.09.020","article-title":"CD4 T cell responses to flaviviruses","volume":"108","author":"Aberle","year":"2018","journal-title":"J Clin Virol"},{"key":"2023101805453593200_jiad193-B157","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.virol.2011.12.012","article-title":"A West Nile virus CD4 T cell epitope improves the immunogenicity of dengue virus serotype 2 vaccines","volume":"424","author":"Hughes","year":"2012","journal-title":"Virology"},{"key":"2023101805453593200_jiad193-B158","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00089-20","article-title":"T cell responses induced by attenuated flavivirus vaccination are specific and show limited cross-reactivity with other flavivirus species","volume":"94","author":"Grifoni","year":"2020","journal-title":"J Virol"},{"key":"2023101805453593200_jiad193-B159","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1128\/JVI.02129-14","article-title":"The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes","volume":"89","author":"Weiskopf","year":"2015","journal-title":"J Virol"},{"key":"2023101805453593200_jiad193-B160","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1749-6632.2001.tb02704.x","article-title":"Antibody prophylaxis and therapy for flavivirus encephalitis infections","volume":"951","author":"Roehrig","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"2023101805453593200_jiad193-B161","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000823","article-title":"The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1","volume":"6","author":"Shrestha","year":"2010","journal-title":"PLoS Pathog"},{"key":"2023101805453593200_jiad193-B162","article-title":"Landscape of monoclonal antibodies targeting Zika and dengue: therapeutic solutions and critical insights for vaccine development","volume":"11","author":"Dussupt","year":"2020","journal-title":"Front Immunol"},{"key":"2023101805453593200_jiad193-B163","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev-immunol-042718-041309","article-title":"Human antibodies for viral infections","volume":"40","author":"Crowe JE","year":"2022","journal-title":"Annu Rev Immunol"},{"key":"2023101805453593200_jiad193-B164","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/228\/Supplement_6\/S398\/52209347\/jiad193.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/228\/Supplement_6\/S398\/52209347\/jiad193.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T02:20:11Z","timestamp":1697595611000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/228\/Supplement_6\/S398\/7320343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,15]]},"references-count":164,"journal-issue":{"issue":"Supplement_6","published-online":{"date-parts":[[2023,10,18]]},"published-print":{"date-parts":[[2023,10,18]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiad193","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,10,15]]},"published":{"date-parts":[[2023,10,15]]}}}